Some interesting oncology results: Millennium's Velcade used in combo therapy for multiple myeloma shows impressive results. Cephalon's Treanda shows impressive remission numbers for CLL, and …
Pharma News 11_9
A huge week for news, especially on the cardiovascular front: Prasugrel, the Lilly/Daiichi-Sankyo blood thinner, was the biggest headline grabber. This potential blockbuster came in with mixed …
Pharma News 9_14
Prasugrel, the upcoming rival to $6 billion drug Plavix, gets a write-up. This is a crucial new drug for co-promote partners Daiichi-Sankyo and Eli Lilly. Good Samaritan drug rep loses leg, gains …
Pharma News 9_7
Merck's new HIV treatment recommended by FDA panel for approval: The advisory panel voted unanimously to recommend marketing approval for the twice-a-day pill, known generically as raltegravir, the …
Pharma News 6_29
Some robust pipelines: Glaxo Oncology, and J&J. Cephalon moving more rapidly on oncology candidate Treanda. Glaxo's cervical cancer vaccine Cervarix looking good. Byetta, a diabetes drug from …
Pharma News 6_8
An Oncology News-fest, during ASCO week: Genentech's Avastin shown to be helpful for kidney cancer. Bayer/Onyx's Nexavar shows hopeful activity for liver cancer. Pfizer's still-experimental …